Cell Fitness Used To Predict COVID-19 Outcomes

Industry news | 21 October, 2021 | CACLP

Original from: Technology Networks

Cell fitness has been identified as a way of predicting health outcomes in COVID patients, according to a University of Queensland study.

The study investigated a cellular fitness marker, known as hfwe-Lose, to identify sub-optimal cells in patients who had been hospitalised or died from COVID at the start of the pandemic.

UQ Diamantina Institute’s Dr Arutha Kulasinghe said researchers conducted post-mortem analysis on COVID-infected lung tissues and found that the cell fitness marker influenced a person’s immune response to infection.

“We found that patients with acute lung injury had higher levels of the biomarker in their lower respiratory tract and areas of cell death,” Dr Kulasinghe said.

“More importantly, we also found that the cell fitness marker outperformed conventional methods, such as age, inflammation and co-existing diseases, in predicting health outcomes, such as hospitalisation and death, in COVID patients.”

Assessing the level of risk in developing severe COVID infection is an important consideration in the management of the current pandemic.

Dr Kulasinghe said the study findings might be useful in the early triage of patients who test positive for COVID as the cell fitness marker could be identified via a simple nasal swab.

“The cell fitness marker would enable medical teams to identify patients more likely to develop severe symptoms, provide closer monitoring and earlier access to hospitalisation and intensive care,” he said.

“We are now looking to validate our findings in larger patient populations to determine the robustness of the marker.

“The cell fitness marker is part of the body’s process for removing unwanted cells."

Source: Cell Fitness Used To Predict COVID-19 Outcomes

Filed under：

FDA

Press contact

CACLP - The largest IVD Expo & Conference

Back to list

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

Name *
Email *
Company name *
Country *

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Cell Fitness Used To Predict COVID-19 Outcomes

Most popular

MGI Tech Partners with Dasa to Enhance Health Diagnosis with Genetic Sequencing in Brazil

Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Sysmex Inostics Gets NYS CLEP Approval for Clinical Trial Use of Liquid Biopsy Assay

LuminUltra Acquires Legionella Testing Business from Genomadix and Inks Strategic License to Commercialize Additional Tests for Ultra-portable Molecular Diagnostic Platform

Stay in touch with CACLP News

Subscribe to CACLP News

Thank you for subscribing to CACLP News!